ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2024-03-28  |  UPDATED: 1402/11/15 - 18:13:1 FA | AR | PS | EN
Formation of the Federalist Assembly of Afghanistan             Israel launches missile attack on outskirts of Damascus, killing Syrian civilians             UK national scandal: 20,000 mental health patients raped, sexually assaulted in NHS care             Three US troops killed, dozens injured in drone attack in Syria             Trump says NATO will not come to rescue if US attacked             Ukraine beset by $40m fraud in arms procurement amid war with Russia            US approves sale of F-16 jets to Turkey after Ankara ratifies Swedens NATO membership             UNSC to meet to discuss ICJ ruling on Israeli genocide in Gaza             Taliban: Afghanistan Does Not Have Formal Border With Pakistan             Gazas major health facility collapses amid Israeli attacks: MSF             Americans to redeploy nuclear weapons in UK amid fears of WW3             Biden makes history: 1st sitting US president sued for complicity in genocide             Trump walks out of courtroom during closing arguments of Carrolls attorney            US: 3 dead in shooting at Texas apartment complex            US-UK aggression against Yemen risks expansion of war: Iran            


DATE PUBLISHED: 2014/4/22 - 12:12:18
VISIT: 2424
SHARE WITH YOUR FRIENDS

Spinal Cord Damage May Be Fixed with New Therapies
Spinal Cord Damage May Be Fixed with New Therapies

These findings suggest future therapies could help repair nerve damage after people suffer spinal cord injury or brain trauma, researchers said.

Damage to the central nervous system — the brain and spinal cord — is currently irreparable. This often leaves those who suffer from spinal cord injury, stroke or brain trauma with serious impairments such as paralysis and loss of sensation, Science News reported.

In contrast, people with nerve damage in their peripheral nervous system, which controls areas of the body outside the brain and spinal cord, have about 30 percent of the nerves grow back, and there is often recovery of movement and function.

"Due to the complexity of the structure of the central nervous system, regrowth leads most often to incorrect rewiring, such as pain," said study author Simone Di Giovanni, a neuroscientist and neurologist at Imperial College London. "The peripheral nervous system is much more simple and has effective, although partial, regeneration."

Most spinal cord injuries are caused by damage to axons, the long extensions of neurons that send messages around inside the nervous system. Di Giovanni and his colleagues wanted to discover why axons in the peripheral nervous system seem to make a vigorous effort to grow back when damaged, whereas axons in the central nervous system mount little to no effort.

They found that when nerves are damaged in the peripheral nervous system, they emit signals to switch on a program to initiate nerve growth. This program is "epigenetic," meaning that without altering DNA, it can activate or deactivate genes. This is the first demonstration of a specific epigenetic mechanism responsible for nerve regeneration.

The researchers pinpointed a protein, called P300/CBP-associated factor (PCAF), as being central to initiating nerve regrowth. They found that when this protein was injected into mice that had damage to their central nervous system, it significantly increased the number of nerve fibers that grew back.

"This work opens an exciting new field of investigation, placing epigenetic regulation as a new, very promising tool to promote regeneration and recovery after spinal injury," Di Giovanni told Live Science.

"The ultimate goal could be to develop a pharmaceutical method to trigger the nerves to grow and repair, and to see some level of recovery in patients," Di Giovanni said in a statement. "We are excited about the potential of this work, but the findings are preliminary."

"The next step is to see whether we can bring about some form of recovery of movement and function in mice after we have stimulated nerve growth through the mechanism we have identified," Di Giovanni said. Eventually, the research could lead to a drug that could be tested in people, although there are many hurdles to overcome first, he said.

In another study, scientists investigated the scar tissue in spinal cords that forms after injuries to axons. These scars prevent damaged nerves from regrowing.

Past research suggested one way to promote the growth of injured spinal nerve cells was to administer an enzyme known as chondroitinase ABC (ChABC), which digests scar-forming proteins. However, because this enzyme breaks down quickly, maintaining these beneficial effects for a long time would require repeatedly administering the enzyme to the spinal cord.

Instead of repeatedly injecting this enzyme into the spinal cord, researchers have explored using gene therapy as a way to get spinal cord cells to manufacture the enzyme themselves. Gene therapy injects cells with the genes for proteins such as enzymes.

Scientists at King's College London and their colleagues used a single injection to deliver their ChABC gene therapy into the spinal cord of injured adult rats.

The gene therapy led the rat spinal cord cells to generate large amounts of the scar-busting enzyme in the damaged areas. Within 12 weeks, the rodents recovered their hind limb function and were able to navigate the rungs of a horizontal ladder.

"These findings provide convincing evidence that gene therapy with chondroitinase not only encourages the sprouting of injured axons, but also imparts significant protection to nerve cells," neuroscientist Mark Tuszynski at the University of California, San Diego, who was not involved in this study, said in a statement. "These are new and important findings that could lead to the development of testable therapies for spinal cord injury in people."

A key note of caution: "There is far more research to be carried out before this sort of treatment could ever be considered for any form of clinical testing," study author Nicholas James, a neuroscientist at King's College London, told Live Science.

One criticism of the research will be that the researchers used a virus that integrates genes into the genomes of cells, which has the potential to cause problems such as cancer. James noted their collaborators are working on gene therapy techniques that do not involve viruses integrating genes into target cells.

 

LINK: https://www.ansarpress.com/english/1814






*
*

*



SEE ALSO

Report : Spinal implant helps a person with advanced Parkinsons disease walk without falling


Over $250 million of counterfeit HIV treatments sold


In a first, man gets heart transplant from genetically altered pig


Pandemic babies may have slight development lag study


Omicron 2nd most contagious virus known to mankind US doctor


MSF reports basic medical needs of Afghans are not being met


Miami Doctor Dies After Getting Pfizer COVID-19 Vaccine, Reports Say


Iranian and Afghan medical universities sign MoU to strengthen relations


British coronavirus vaccine: Human trials to include 10,000


Oxford-based pharmatech company uses artificial intelligence to find drug against COVID-19





VIEWED
MOST DISCUSSED




POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

Federalism in Afghanistan: Opportunities and Challenges

Formation of the Federalist Assembly of Afghanistan

Israel launches missile attack on outskirts of Damascus, killing Syrian civilians

UK national scandal: 20,000 mental health patients raped, sexually assaulted in NHS care

Three US troops killed, dozens injured in drone attack in Syria

Trump says NATO will not come to rescue if US attacked

Ukraine beset by $40m fraud in arms procurement amid war with Russia

US approves sale of F-16 jets to Turkey after Ankara ratifies Swedens NATO membership

UNSC to meet to discuss ICJ ruling on Israeli genocide in Gaza

Taliban: Afghanistan Does Not Have Formal Border With Pakistan

Gazas major health facility collapses amid Israeli attacks: MSF

Americans to redeploy nuclear weapons in UK amid fears of WW3

Biden makes history: 1st sitting US president sued for complicity in genocide

Trump walks out of courtroom during closing arguments of Carrolls attorney

US: 3 dead in shooting at Texas apartment complex

US-UK aggression against Yemen risks expansion of war: Iran

Yemen directly hits US warship with ballistic missile

Hamas has self-reliantly opposed the three giant intelligence agencies of the world!

President Raeisi calls for UN reform, says body unable to end Gaza genocide

Pedram: The Abduction of Hazara and Tajik Women Recalls the Crimes of Abdur Rahman

Special envoys from G7 countries discuss Afghanistan in London meeting

Turkish lawmakers open debate over Swedens NATO membership

UN agency says over half a million Palestinians face catastrophic hunger in Gaza

Palestinian Islamic Jihad: Al-Maghazi operation proved defeat of Israeli regime in Gaza war

European support for Israel damaging energy security on the continent, report says

Pakistan Army Kills Seven Terrorists Near Afghan Border

Israel kills at least 190 people in Khan Younis in 24 hours

UNAMA report: 49 Hazara community members killed in Afghanistan in three months

Indias Modi inaugurates Hindu temple on site of razed mosque ahead of elections

US 2024 election: DeSantis drops out of Republican presidential race, backs Trump

Survivors of Russian charter flight crash transferred to Kabul

Irans anti-terror strikes clear message to certain recipients: Foreign Ministry

Ethnic mass killings in one Sudan city last year left up to 15,000 dead: UN report

Iran says reserves right to avenge Israels assassination of IRGC advisors

Rocket barrage targets Ain al-Asad base housing US forces in western Iraq

Lebanese media: Israeli drone kills 2 Hamas members in southern Lebanon

Five IRGC advisors assassinated in Israeli aggression on Syria

Pakistan recalls ambassador from Tehran

Iraqi PM stresses to NATO chief ending of foreign troops

UN chief reiterates call for immediate ceasefire in Gaza


MEDICAL NEWS


ANSAR PRESS  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. Ԑ یی